Methcathinone (MCAT; 1), the progenitor of numerous
and widely abused “synthetic cathinone” central stimulants,
exists as a pair of optical isomers. Although S(−)MCAT
is several-fold more potent than R(+)MCAT in rodent
locomotor stimulation and in stimulus generalization studies in rat
drug discrimination assays, the individual optical isomers of MCAT
have never been directly compared for their actions at monoamine transporters
that seem to underlie their actions and have never been examined for
their relative abuse potential. Here, we found that the isomers of
MCAT are nearly equieffective at dopamine and norepinephrine transporters
(DAT and NET, respectively) as transporter substrates (i.e., as releasing agents) and are ≥63-fold less potent at the
serotonin transporter (SERT). In intracranial self-stimulation (ICSS)
studies to evaluate abuse-related drug effects in rats, S(−)MCAT was approximately twice as potent as its R-enantiomer. Achiral analogs, α-methyl MCAT (3) and α-des-methyl MCAT (4),
also were DAT/NET substrates and also produced abuse-related ICSS
effects, indicating that they retain abuse potential and that they
might be useful for the further study of the stereochemistry of synthetic
cathinone analogs with chiral β- (or other) substituents.